GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 112 filers reported holding GENOMIC HEALTH INC in Q4 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $30,093,000 | +13.8% | 1,023,933 | +12.0% | 0.01% | +20.0% |
Q3 2016 | $26,433,000 | +17.9% | 914,017 | +5.5% | 0.01% | 0.0% |
Q2 2016 | $22,426,000 | +6.7% | 866,021 | +2.1% | 0.01% | 0.0% |
Q1 2016 | $21,016,000 | -26.6% | 848,433 | +4.3% | 0.01% | -28.6% |
Q4 2015 | $28,642,000 | +53.3% | 813,704 | -7.8% | 0.01% | +40.0% |
Q3 2015 | $18,682,000 | -19.4% | 882,888 | +5.9% | 0.01% | -16.7% |
Q2 2015 | $23,171,000 | -8.0% | 833,783 | +1.2% | 0.01% | 0.0% |
Q1 2015 | $25,181,000 | -1.6% | 824,251 | +3.0% | 0.01% | 0.0% |
Q4 2014 | $25,592,000 | +21.5% | 800,501 | +7.6% | 0.01% | 0.0% |
Q3 2014 | $21,061,000 | +4.1% | 743,935 | +0.8% | 0.01% | 0.0% |
Q2 2014 | $20,227,000 | -3.5% | 738,214 | -7.2% | 0.01% | 0.0% |
Q1 2014 | $20,963,000 | -6.2% | 795,858 | +4.2% | 0.01% | -14.3% |
Q4 2013 | $22,346,000 | -4.9% | 763,429 | -0.6% | 0.01% | -12.5% |
Q3 2013 | $23,495,000 | +11.9% | 768,328 | +16.0% | 0.01% | 0.0% |
Q2 2013 | $21,002,000 | – | 662,327 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |